Risks

Days sales outstanding near 396 days versus faster-paying peers can pressure working capital and cash visibility, especially if reimbursement timing remains uneven.

Days payables outstanding near 390 days suggests supplier financing dependence, which can tighten terms and compress margins versus peers with cleaner cash cycles.

Interest coverage reported at zero limits visibility into debt service capacity, leaving HCAI more exposed than better-capitalized peers if funding costs rise.

Current ratio of 1.76 supports near-term liquidity, but it is only moderately above peers with stronger cash buffers, limiting downside protection in stress scenarios.

Opportunities

Net debt to EBITDA is effectively flat, giving HCAI more balance-sheet flexibility than leveraged peers to fund growth or absorb reimbursement volatility.

Debt-to-equity near zero reduces financial drag versus indebted peers, supporting greater resilience if operating conditions soften or capital access tightens.

Current and quick ratios of 1.76 indicate adequate liquidity, which compares favorably with peers that face tighter working-capital constraints in healthcare services.

A very short cash conversion cycle, despite receivables and payables distortion, can support operating flexibility versus peers with structurally longer cash needs.

Overall Score

HCAI’s near-zero leverage and adequate liquidity support positioning versus peers, but very slow receivables collection and weak interest coverage constrain realized upside.